Eight months ago the XRP ETFs launched faster than any product since Ethereum. The bid has since decayed 99%, from $200 million weeks to zero-flow days, leaving $1.49 billion invested, $997 million remaining, and a recovery thesis outsourced entirely to a Senate vote. Here is the full autopsy of a bid, and what its flatline actually prices.
Summary
- US spot XRP ETFs launched in November with $667 million in their first month, reaching $1 billion faster than any crypto product since Ethereum’s funds, on an eight-week inflow streak that ran even while Bitcoin funds bled.
- The bid then decayed by roughly 99%: weekly flows fell from above $200 million to low single-digit millions, the streak ended July 13, and July’s tape shows zero-flow days punctuated by one $7.29 million outflow, the largest since March.
- The wreckage is precise: $1.49 billion in cumulative inflows now marks against roughly $997 million in net assets, an unrealized deficit near $493 million, with 82% of assets concentrated in three funds and several products flatlined entirely.
- The one institutional trophy, Goldman Sachs’s $153.8 million position across four funds, is a December-dated 13F snapshot that Bloomberg analysts read as trading-desk facilitation, inside a complex that remains 84% retail-held.
- The flows have now stabilized at approximately nothing, which the optimistic read calls a floor, and the recovery case has converged on a single external event: the CLARITY Act vote whose odds trade near a coin flip this week.
There is a specific moment in the life of every investment product when its story stops being about demand and starts being about anatomy, and for the US spot XRP ETFs that moment can be dated: Monday, July 13, when the daily flow printed zero and an eight-week inflow streak, the product class’s last living narrative, quietly ended. What launched in November as the fastest-growing crypto fund complex since Ethereum’s, $667 million in month one, a billion dollars faster than anyone forecast, institutional validation in fund form, now trades as a case study. The buyers did not rotate, rebalance, or pause. They stopped: from weeks above $200 million to weeks near $2 million, from streak to zero-days, from launch euphoria to a July whose single best session, $6.78 million, amounts to one percent of the early pace. What remains is $1.49 billion of invested capital marking against $997 million of assets, three funds carrying 82% of everything, and a recovery thesis that no longer references the product at all, only a Senate vote. This piece is the full anatomy: how the bid died, what the wreckage precisely looks like, what the lone institutional trophy in the filings actually shows, and what the flatline, honestly read, prices for the asset underneath it.
The decay curve, dated
The complex’s eight months divide into three phases so distinct they could belong to different products.
Phase one, the launch bid, ran from November into the winter: $667 million in the first month across seven issuers, the fastest accumulation to $1 billion since Ethereum’s funds, weekly prints above $200 million, and the statistic the marketing decks will never retire, an inflow streak that persisted through weeks when Bitcoin ETFs bled, which was read at the time as evidence of a distinct, durable XRP allocator base. The reading had support: the products launched into the afterglow of the SEC’s surrender, the commodity classification, and the first wave of bank-desk research initiating coverage with conditional price targets in the double digits.
Phase two, the decay, occupied the spring: weekly flows stepped down from nine figures to eight to seven, May still collected over $100 million for the month, and by June the run-rate had thinned to low single-digit millions per week, a decline of roughly 99% from peak that no single event explains and one variable tracks perfectly, the token’s price, which fell from above $2.40 in January to the $1.10s, converting every earlier allocation into a loss and every allocator’s quarterly review into an uncomfortable meeting. Fund flows follow performance with a lag in both directions; the launch streak was the up-lag, and the decay was the down-lag arriving on schedule.
Phase three, the flatline, is July: six sessions of exactly zero flows in the month’s first half, a $7.29 million single-day outflow on July 9, the largest since March, the streak’s formal end on July 13, then a stretch from July 10 through July 20 of zeros and small positives, crowned by the month’s best day, $6.78 million on July 16, driven by two issuers’ desks. The freshest coverage frames the stabilization as survival, the product has not seen an outflow day since July 9, and the framing is technically true and proportionally absurd: the bid that defined the launch is not resting, it is absent, and its absence has become stable. That is what the anatomy shows. The interesting questions are in the tissue.
The wreckage, itemized
Four numbers, current as of this week’s data, describe the complex more honestly than any narrative.
$1.49 billion against $997 million. Cumulative net inflows since launch stand near $1.49 billion; total net assets stand near $997 million, roughly 1.45% of XRP’s market capitalization, with about 971 million XRP in custody. The gap, approximately $493 million, is the unrealized loss the allocator base collectively carries, the arithmetic consequence of buying a token averaging well above $1.50 that now trades near $1.10. Every future flow decision the complex’s holders make is made against that deficit, which is the single most important fact in any forecast of the flows resuming: the marginal buyer is being asked to average down into a product whose existing buyers are 33% underwater on invested capital.
82% in three funds. Bitwise holds $312.8 million in assets on $498.3 million of cumulative inflows; Canary $253.2 million on $467.0 million; Franklin $252.2 million on $415.6 million. Together, the top three hold roughly 82% of complex assets, which means the seven-fund complex is functionally a three-fund market with a long tail of products printing zeros. Category-level flow headlines obscure this: an inflow day increasingly means one or two distribution desks had a decent Thursday, and a diversified institutional bid, the launch thesis, would not produce this shape.
84% retail-held. The complex’s ownership base, per the issuer-side analysis that accompanied the spring’s institutional reporting, remains 84% retail, against 48.8% institutional participation in the comparable Solana products, a gap that quantifies how much of the launch narrative, the institutions are here, was distribution, not description. Which frames the trophy correctly.
The Goldman position, read properly. Goldman Sachs’s 13F disclosed $153.8 million across four XRP funds, roughly $40 million in Bitwise, $38.5 million in Franklin, $38 million in Grayscale, $36 million in 21Shares, making it the largest disclosed institutional holder, accounting for 73% of the top 30 institutions’ combined $211 million. The number did real narrative work all spring, and its caveats are the anatomy lesson: it is a December 31 snapshot, disclosed in March, of positions that may not exist today; Bloomberg’s analysts read the four-fund construction as consistent with trading-desk facilitation and client positioning instead of proprietary conviction; and as this publication’s own guide to how to read the Goldman position argues, the form is a rear-view mirror with a 45-day delay, structurally incapable of showing whether the bank held, added, or exited through the subsequent drawdown. The largest institutional XRP position on record is, read strictly, evidence that Goldman’s clients wanted exposure in December. The flows since are evidence of what everyone wanted after.
The geography of the remaining bid
One more layer of the anatomy deserves its own examination, because the aggregate US flow numbers conceal a compositional fact with real information in it: through the American flatline, the marginal bid for exchange-traded XRP exposure migrated abroad.
Through the spring decay, European venues carried a share of global XRP product flows out of proportion to their size, with Swiss and broader European ETP wrappers at times representing the substantial majority of weekly net inflows worldwide while the US complex printed its zeros. The absolute sums are modest, European crypto ETPs are an older, smaller, steadier market, but the composition matters for what it falsifies and what it suggests. It falsifies the strongest form of the exhaustion reading: if the asset’s entire allocator universe were fully purchased, the European bid would have flatlined alongside the American one, and it did not. And it suggests where the marginal buyer actually lives: in jurisdictions where the asset’s legal status was never contested, where MiCA-era frameworks settled classification questions years earlier, and where the products consequently trade as ordinary alternatives allocations, not as bets on a Senate calendar.
Read that way, the geographic split becomes the cleanest natural experiment available on the outsourced thesis. The American flows died in the jurisdiction where the asset’s status remains hostage to legislation; the European flows persisted, modestly, in jurisdictions where it does not. If legal permanence is truly the binding constraint on institutional allocation, the CLARITY experiment has already run abroad, and its result, steady but unspectacular demand, prices the upper bound of what passage realistically unlocks: not the JPMorgan-forecast flood, but a normalization to the European pattern, mid-single-digit millions weekly, compounding quietly, unheroically, forever. That is a real bull case, and it is a fraction of the one being marketed.
The alternative reading restores the American market’s exceptionalism: US wealth-management distribution is an order of magnitude deeper than Europe’s, the RIA channel that turned Bitcoin’s ETFs into a $52 billion complex has no European equivalent, and the launch month’s $667 million showed what that distribution can move when it has a story to sell. On this reading, Europe measures the floor of post-CLARITY demand and America’s launch month measured the ceiling, and the truth, as usual, books a room between them. Either way, the geographic ledger deserves a place in every flow analysis this complex receives, because it is the one dataset showing what XRP demand looks like when Washington is not the variable, and it has been quietly reporting that answer, in Swiss francs, all year.
The regulated-channel counterpoint
One dataset complicates the pure decay story, and honesty requires it: while the spot complex flatlined, the regulated derivatives channel set records.
CME’s XRP futures built to a peak of $1.4 billion in open interest with 29 large open-interest holders, a record for the venue, even as total XRP derivatives open interest across all venues collapsed from its $10 billion peak by margins reported between 75% and 96%, a deleveraging that wiped out the offshore, retail-levered complex. The split matters because the two channels answer different questions: aggregate open interest tracks speculative leverage, which is gone, while CME positioning tracks the institutions that clear through Chicago, which grew through the wreckage. The honest synthesis is narrower than either headline: the levered retail market deflated, a smaller regulated market matured, and neither flow bought spot tokens, which is why the ETF shelf and the price both starved while the derivatives venue celebrated. Institutional infrastructure and institutional demand are different things, a distinction this asset’s whole history keeps teaching. For the underlying distribution picture, crypto.news has also mapped the supply map under the products.
What the flatline prices
Strip the anatomy to its meaning and three readings compete, with the tape currently endorsing the bleakest.
The floor reading, the optimists’ case, holds that the shakeout is complete: outflows never cascaded, the post-July 9 tape shows zero net redemption, the deficit is carried rather than capitulated, and a stabilized base at $1 billion of assets is the platform a catalyst builds on. Its evidence is real, the complex genuinely did not unwind the way GBTC-era products did, and its weakness is that a floor with no bid above it is just a ledge.
The exhaustion reading holds that the launch consumed the entire natural buyer base: the crypto-native allocators, the RIA early adopters, and the bank desks servicing client curiosity all bought in the first two quarters, at prices 40% above the current market, and no second cohort exists at any price the first cohort’s losses will allow advisers to recommend. On this reading the flatline is not a floor but a completed distribution, and the zero-days are what a fully-sold product looks like.
And the outsourced reading, the one the complex’s own defenders now lead with, holds that the flows return when Washington acts: legal permanence unlocks the institutional allocation the launch never actually contained, the 84% retail share inverts, and the JPMorgan-style first-year forecasts the complex undershot get a second life under a market-structure law. This is the reading that matters, because it is the one being priced, and its honest form is uncomfortable: it concedes the product failed to generate durable demand on its own and converts the entire recovery case into a claim about one bill, whose cloture count stands unresolved this very week, whose passage odds trade near a coin flip, and whose own conditional structure, as this publication’s analysis of the conditional targets riding these flows showed, was already the load-bearing wall under every double-digit XRP forecast. The ETF complex, the price targets, and now the flow-recovery thesis have all converged on the same single point of failure. That is not diversification of catalysts. It is concentration, in a legislature, measured at 41% on Polymarket, and the flatline is what an asset looks like while it waits on it.
What to watch
The weekly prints against the zero line. The complex has proven it can avoid outflows; the open question is whether anything above $10 million a week ever returns without a legislative trigger. Sustained mid-eight-figure weeks would falsify the exhaustion reading on their own.
The concentration ratio. Watch whether the three-fund share of assets rises above 82%, consolidation continuing, or whether the tail products show life, the only clean signal of a broadening buyer base instead of two sales desks working.
The CLARITY binary, and the day after. Passage would run the outsourced thesis’s experiment in real time: the flows either arrive within weeks, validating everything, or they do not, which would be the most damaging data point in the asset’s institutional history, because it would exhaust the last explanation. Failure of the bill runs the mirror experiment on the deficit’s holders. That is the event the recovery thesis waits on.
The Q1 13F cycle’s ghosts. The May filings covering the drawdown quarter will show whether Goldman and the top-30 cohort held through the decline. A largely intact institutional roster supports the floor reading; a vanished one completes the anatomy.
Eight months ago the XRP ETFs were the proof that institutional demand existed. The anatomy shows what they actually proved: that distribution existed, that a launch window monetized it, and that demand, the durable kind that buys drawdowns, was never located. The complex now holds $997 million, a $493 million scar, and one hypothesis left to test, scheduled for a Senate floor that has not yet set the time. Products usually die of redemption. This one’s fate is stranger: fully built, fully priced, and waiting, with the rest of its asset class, for Washington to tell it whether the buyers were ever real. For context, crypto.news has explained he flow machinery itself.
Frequently asked questions
What happened to the XRP ETF inflows?
They decayed roughly 99% from launch. The products drew $667 million in their first month from November and sustained an eight-week inflow streak, but weekly flows fell from above $200 million to low single-digit millions by summer. The streak ended July 13, July logged six zero-flow sessions and a $7.29 million outflow day, and the month’s best session brought just $6.78 million.
How much money is in the funds now, and what is the loss?
Cumulative net inflows stand near $1.49 billion, while total net assets are roughly $997 million, about 1.45% of XRP’s market capitalization, with approximately 971 million XRP in custody. The gap of roughly $493 million represents unrealized losses on invested capital, reflecting purchases made at substantially higher token prices than the current $1.10 area.
Which funds dominate the complex?
Three of seven: Bitwise with $312.8 million in assets, Canary with $253.2 million, and Franklin with $252.2 million, together roughly 82% of all complex assets. The remaining products frequently print zero daily flows, meaning category-level inflow headlines usually reflect activity at one or two distribution desks, not broad-based demand.
Does Goldman Sachs’s position change the picture?
Less than headlines suggested. Goldman’s $153.8 million across four funds, disclosed in its Q4 2025 13F, made it the largest institutional holder, about 73% of the top 30 institutions’ combined exposure. But the filing is a December 31 snapshot published in March, Bloomberg analysts read the construction as trading-desk facilitation rather than directional conviction, and the complex overall remains 84% retail-held.
How does the CME futures record fit the story?
As a counterpoint about a different market. CME’s XRP futures reached a record $1.4 billion in open interest with 29 large holders even as total XRP derivatives open interest collapsed as much as 96% from its $10 billion peak. The regulated channel matured while offshore leverage deflated, but neither development bought spot tokens, which is why the ETF flows and the price starved simultaneously.
Is the recent stabilization a positive signal?
It is the debated question. Since the July 9 outflow, daily flows have been zero or slightly positive, no redemption cascade has occurred, and the deficit is being carried rather than capitulated, the floor reading. The skeptical reading calls the same tape exhaustion: the natural buyer base fully purchased during launch and no second cohort exists at current prices. The flatline is consistent with both until something moves.
Why does everything now depend on the CLARITY Act?
Because every other catalyst has been consumed. The SEC resolution, the launches, and the bank coverage all occurred, and the flows died anyway, leaving legal permanence as the last untested explanation for why institutional allocation has not arrived. The recovery thesis for the flows, the analyst price targets, and the asset’s broader institutional case have converged on the same legislative binary, currently priced near a coin flip.
What should investors watch next?
Weekly flows against the zero line, with sustained mid-eight-figure weeks as the falsifier of the exhaustion reading; the three-fund concentration ratio, for any sign of a broadening base; the Q1 13F filings covering the drawdown quarter, to see whether the institutional roster held; and the CLARITY vote itself, whose aftermath in either direction runs the decisive experiment on whether the buyers return. This is not investment advice.
Disclaimer: This article is for information and educational purposes only and does not constitute financial or investment advice. Flow figures and asset values change daily and reflect data available at the time of writing. Nothing here is a recommendation to buy, sell, or hold any asset or fund. Always do your own research. Information is accurate as of July 24, 2026.
